Brucellosis as a cause of hyperferritinemia in systemic arthritis

2021 ◽  
Author(s):  
Abdulaziz Muhammad Alrowais ◽  
Areej Ahmed Albelali ◽  
Jubran Theeb Alqanatish
Keyword(s):  
Systemic Arthritis

scholarly journals P69 Presenting clinical features of systemic arthritis of JIA: 71 patients—Chennai study

2006 ◽  
Vol 1 (3) ◽  
pp. 170-171
Author(s):  
R Ravichandran ◽  
RC Panchapakesa ◽  
N Vasanthy ◽  
P Kanakarani ◽  
S Rukmangatharajan ◽  
...  
Keyword(s):  
Clinical Features ◽  
Systemic Arthritis

An adult case of severe hand-foot-mouth disease accompanying persistent fever and systemic arthritis

2012 ◽  
Vol 18 (8) ◽  
Author(s):  
Masami Toya ◽  
Yuichiro Endo ◽  
Hideaki Tanizaki ◽  
Akihiro Fujisawa ◽  
Miki Tanioka ◽  
...  
Keyword(s):  
Mouth Disease ◽  
Adult Case ◽  
Persistent Fever ◽  
Hand Foot Mouth Disease ◽  
Systemic Arthritis

Aspirin-Induced Acute Haemolytic Anaemia in Glucose-6-Phosphate Dehydrogenase-Def icient Children with Systemic Arthritis

1989 ◽  
Vol 81 (4) ◽  
pp. 208-209 ◽  
Author(s):  
Tullio Meloni ◽  
Gavino Forteleoni ◽  
Augusto Ogana ◽  
Vannina Franca
Keyword(s):  
Haemolytic Anaemia ◽  
Glucose 6 Phosphate Dehydrogenase ◽  
Systemic Arthritis

SYSTEMIC ARTHRITIS

2005 ◽  
pp. 291-303 ◽  
Author(s):  
Ross E. Petty ◽  
James T. Cassidy
Keyword(s):  
Systemic Arthritis

Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics

2019 ◽  
Vol 86 (7) ◽  
pp. 590-594 ◽  
Author(s):  
Priyankar Pal ◽  
Prabhas Prasun Giri ◽  
Rajiv Sinha
Keyword(s):  
Systemic Arthritis

scholarly journals Disease-modifying Antirheumatic Drug Use in the Treatment of Juvenile Idiopathic Arthritis: A Cross-sectional Analysis of the CARRA Registry

2012 ◽  
Vol 39 (9) ◽  
pp. 1867-1874 ◽  
Author(s):  
TIMOTHY BEUKELMAN ◽  
SARAH RINGOLD ◽  
TREVOR E. DAVIS ◽  
ESI MORGAN DeWITT ◽  
CHRISTINA F. PELAJO ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Medication Use ◽  
The United States ◽  
Antirheumatic Drug ◽  
Patient Factors ◽  
Cross Sectional ◽  
Biologic Dmard ◽  
Disease Modifying ◽  
Disease Modifying Antirheumatic Drug ◽  
Systemic Arthritis

Objective.To characterize disease-modifying antirheumatic drug (DMARD) use for children with juvenile idiopathic arthritis (JIA) in the United States and to determine patient factors associated with medication use.Methods.We analyzed cross-sectional baseline enrollment data from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry from May 2010 through May 2011 for children with JIA. Current and prior medication use was included. We used parsimonious backward stepwise logistic regression models to calculate OR to estimate associations between clinical patient factors and medication use.Results.We identified 2748 children with JIA with a median disease duration of 3.9 years from 51 US clinical sites. Overall, 2023 (74%) had ever received a nonbiologic DMARD and 1246 (45%) had ever received a biologic DMARD. Among children without systemic arthritis, methotrexate use was most strongly associated with uveitis (OR 5.2, 95% CI 3.6–7.6), anticitrullinated protein antibodies (OR 4.5, 95% CI 1.7–12), and extended oligoarthritis (OR 4.1, 95% CI 2.5–6.6). Among children without systemic arthritis, biologic DMARD use was most strongly associated with rheumatoid factor (RF)-positive polyarthritis (OR 4.3, 95% CI 2.9–6.6), psoriatic arthritis (PsA; OR 3.0, 95% CI 2.0–4.4), and uveitis (OR 2.8, 95% CI 2.1–3.7). Among children with systemic arthritis, 160 (65%) ever received a biologic DMARD; tumor necrosis factor inhibitor use was associated with polyarthritis (OR 2.5, 95% CI 3.8–16), while interleukin 1 inhibitor use was not.Conclusion.About three-quarters of all children with JIA in the CARRA Registry received nonbiologic DMARD. Nearly one-half received biologic DMARD, and their use was strongly associated with RF-positive polyarthritis, PsA, uveitis, and systemic arthritis.

Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis

2012 ◽  
Vol 22 (4) ◽  
pp. 558-564 ◽  
Author(s):  
Remi Ozawa ◽  
Yutaka Inaba ◽  
Masaaki Mori ◽  
Ryoki Hara ◽  
Masako Kikuchi ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Systemic Arthritis

scholarly journals Report of a rare case of hand-foot-mouth disease in a adult woman with systemic arthritis

2016 ◽  
Vol 19 (4) ◽  
pp. 125
Author(s):  
Luciana Eloísa Da Silva Castro Nóbrega ◽  
Viviane Alves De Oliveira ◽  
Patrícia Teixeira De Oliveira ◽  
Éricka Janine Dantas Da Silveira ◽  
Ana Myriam Costa De Medeiros
Keyword(s):  
Infectious Disease ◽  
Rare Case ◽  
Correct Diagnosis ◽  
Delayed Diagnosis ◽  
Mouth Disease ◽  
Intestinal Infection ◽  
Mouth Diseases ◽  
Hand Foot Mouth Disease ◽  
History Of ◽  
Systemic Arthritis

<p>Hand-foot-mouth disease (HFMD) is a highly infectious disease, rare in adults which usually presents a painfull stomatitis. We describe a rare case of HFMD in a 34-year-old woman with medical history of recent intestinal infection and systemic arthritis with only oral and hands involvement. Additionally, we discuss diagnosis and treatment of this disease and reinforce the importance of the correct diagnosis because delayed diagnosis can cause spread of the disease.</p><p><strong>Keywords:</strong> Adult; Arthritis; Mouth diseases.</p>

scholarly journals The Vaccine Coverage and Vaccine Immunity Status and Risk Factors of Non-Protective Levels of Antibodies Against Vaccines in Children with Juvenile Idiopathic Arthritis: Russian Tertiary Centre Study.

2021 ◽  
Author(s):  
Mikhail Kostik ◽  
Natalia A. Lubimova ◽  
Irina V. Fridman ◽  
Olga V. Goleva ◽  
Susanna M. Kharit
Keyword(s):  
Risk Factors ◽  
Hepatitis B ◽  
Vaccine Coverage ◽  
Immunosuppressive Drugs ◽  
Protective Level ◽  
Tertiary Centre ◽  
Methotrexate Treatment ◽  
Systemic Arthritis ◽  
Vaccine Immunity

Abstract Background: Immunosuppressive drugs, decreased vaccine coverage, aberrant immunity might be factors of low anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-vaccine immunity and risk factors of non-protective levels of antibodies against measles, mumps, rubella, hepatitis B and diphtheria in JIA patients. Methods: A prospective study included 170 children diagnosed with JIA aged 2 to 17 years, who received routine vaccinations against measles, rubella, mumps (MMR) diphtheria and hepatitis B. In all patients, the levels of post-vaccination antibodies (IgG) for measles, rubella, mumps, hepatitis B and diphtheria measured with ELISA.Results: Protective level of antibodies were 50% against hepatitis B, 52% - diphtheria, 58% - measles, 80% - mumps, 98% rubella. The best coverage for MMR had patients with enthesytis-related arthritis-85%, compare to oligoarthritis-70%, polyarthritis-69%, systemic arthritis-63%. Diphtheria coverage was 50%, 51%, 46%, 63%, respectively. Incomplete MMR vaccination had 39% patients, treated with biologics, 22% with methotrexate and 14% with NSAID (p=0.025), and 61%, 46%, 36% for diphtheria (p=0.021). Incomplete vaccination was a risk factor of non-protective level of antibodies against measles (HR=2.03 [95%CI: 1.02; 4.0], p=0.042), parotitis (HR=6.25 [95%CI: 2.13; 17.9], p=0.0008) and diphtheria (HR=2.39 [95%CI: 1.18; 4.85], p=0.016) vaccines, as well as JIA category, biologics, corticosteroids and long-term methotrexate treatment for distinct vaccines.Conclusion: Children with JIA may have lower anti-vaccine antibodies levels and required routine check, especially in children with incomplete vaccination, biologics, systemic arthritis and long-term methotrexate treatment.

Sign in / Sign up

Export Citation Format

Share Document